Koroner Arter Hastalığında Endotelyal Nitrik Oksit Sentaz Geninin Glu 298-Asp Ve T786-C Polimorfizmlerinin Araştırılması

Yıl 2019, Cilt: 3 Sayı: 1, 40 - 48, 25.04.2019

Yücel Kaçmaz Hanefi Yekta Gürlertop Özge Turgay Yıldırım Ercan Akşit Fatih Aydın

https://doi.org/10.30565/medalanya.469411

Öz

Amaç: Bu çalışma ile eNOS geninin Glu298-Asp ve T-786C polimorfizmleri ile Koroner arter hastalığı (KAH) arasındaki ilişkisinin araştırılması ve KAH gelişmesinde rol oynayan genetik faktörlerin aydınlatılmasına katkıda bulunulması amaçlandı. 

Hastalar ve Yöntemler: Çalışmada toplam 200 hasta değerlendirildi. Ciddi KAH, majör koroner arterlerin en az birinde ≥%50 darlık olması olarak tanımlanmış ve bu hastalar KAH grubuna alındı (n=144). Stenozisi olmayan hastalar kontrol grubuna dahil edildi (n=66). 

Bulgular: T-786C polimorfizminin değerlendirilmesi sonucunda, KAH ve kontrol grupları karşılaştırıldığında TT (p=0,660), TC (p=0,73) ve CC (p=0,634) genotipleri arasında anlamlı fark saptanmamıştır. Her iki grupta da dominant (p=0,439) ve rese-sif (p=0,622) model karşılaştırmasında anlamlı fark yoktur. Glu 298-Asp polimorfizmi incelendiğinde; gruplar genotip dağılımlarına göre karşılaştırıldığında, GG (p=0,836), GT (p=0,581) ve TT (p=0,767) genotipleri arasında istatistiksel olarak anlamlı fark bulunmamıştır. Gruplar, hem dominant (p=0,697) hem de resesif (p=0,485) model karşılaştırmalarına göre istatistiksel açıdan benzer bulunmuştur. 

Sonuç: Çalışma sonucunda, T-786 C ve Glu 298-Asp polimorfizmleri ve KAH arasında istatistiksel bir ilişki bulunmamıştır. T-786 C ve Glu 298-Asp polimorfizmlerinin rolünü açıklığa kavuşturmak için daha büyük çalışma popülasyonları ile benzer çalışmalar yapılmalıdır. 

Anahtar Kelimeler

Endotelyal nitrik oksit sentaz, koroner arter hastalığı, nitrik oksit, T-786C polimorfizmi, Glu298-Asp polimorfizmi

Glu 298-Asp And T786-C Polymorphisms Of Endothelial Nitric Oxide Synthase Gene In Coronary Artery Disease Patients

Öz

Aim: We aimed to investigate the association of eNOS gene with Glu298-Asp and T-786C polymorphisms with Coronary artery disease (CAD) and to contribute to the elucidation of the genetic factors involved in the development of CAD. 

Patients and Methods: A total of 200 patients were evaluated. Severe CAD was defined as ≥ 50% stenosis in at least one of major coronary arteries and these patients were taken into the CAD group (n=144). Patients without stenosis were included in the control group (n=66). 

Results: After the evaluation of T-786C polymorphism, there was no significant dif-ference between TT (p=0,660), TC (p=0,73) and CC (p=0,634) genotypes between CAD and control groups. There was no significant difference between the groups in both dominant (p=0,439) and recessive (p=0,622) model comparisons. When Glu 298-Asp polymorphism was examined, there was no statistically significant difference between GG (p=0,836), GT (p=0,581) and TT (p=0,767) genotypes when the groups were compared according to genotype distributions. The groups were statistically similar according to both dominant (p=0,697) and recessive (p=0,485) model com-parisons. 

Conclusion: There was no statistical correlation between T-786 C and Glu 298-Asp polymorphisms and CAD. Similar studies with larger study populations should be conducted to clarify the role of T-786 C and Glu 298-Asp polymorphisms. 

Anahtar Kelimeler

Endothelial nitric oxide synthase, coronary artery disease, nitric oxide, T-786C polymorphism, Glu298-Asp polymorphism

Kaynakça

• 1. Dwivedi A, Al’Aref SJ, Lin FY, Min JK. Evaluation of Atherosclerotic Plaque in Non-invazive Coronary Imaging. Korean Circ J. 2018;48:124-133. PMID:29441745
• 2. Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc. 2009;84:917-38. PMID:19797781
• 3. Hamm CW, Möllmann, H, Bassand JP, Van de Werf F. Acute Coronary Syndrom. In: Camm AJ, Lücher TF, Serruys PW, editors. The ESC Textbook of Cardiovascular Medicine. 2nd ed. New York: Oxford Universty Press; 2009:535-97.
• 4. Kannel WB. Lipids, diabetes and coronary heart disease: insights from the Framingham study. Am Heart J 1985;110:1100-7. PMID:4061265
• 5. Griffin BP. Kardiyovasküler hastalıklar El Kitabı (Çeviri:Erol Ç). dördüncü basım. Erol Ç, E.Atalar. Ankara: Güneş tıp Kitapevleri; 2014:44-64,713-1039.
• 6. Mansur T. Deri Biyolojisinde ve Tedavisinde Nitrik Oksit. T klin Dermatoloji. 2002;12:143-8.
• 7. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, et al. Structure andchromosomal localization of the human constitutive endothelial nitric oxide synthasegene. J Biol Chem 1993;268:17478-88. PMID:7688726
• 8. Davies PF. Multiple signaling pathways in flow-mediated endothelial mechano transduction: PYK-ing the right location. Arterioscler Thromb Vasc Biol 2002;22:1755-7. PMID: 12426200
• 9. Marin J, Rodriguez-Martinez MA. Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol Ther 1997;75:111-34. PMID:9428001
• 10. Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet. 1994;343:1199-206. PMID: 7909873
• 11. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol 2003;199:8-17. PMID:12474221
• 12. Lembo G, De Luca N, Battagli C, Lovino G, Aretini A, Musicco M et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 2001;32:735-40. PMID:11239195
• 13. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y,Nakayama M et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998;32:3-8. PMID:9674630
• 14. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H,Sugiyama S, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998;103:65-9. PMID:9737779
• 15. Miranda JA, Belo VA, Souza-Costa DC, Lanna CM, Tanus-Santos JE. eNOS polymorphism associated with metabolic syndrome in children and adolescents. Mol Cell Biochem. 2013;372:155-60. PMID:22983816
• 16. Klincheva M, Vilarova EA, Angjusheva T, Milev I, Idoski E, Mitrev Z. Endothelial Nitric Oxide Synthase T-786C Mutation, Prothrombin Gene Mutation (G-20210-A) and Protein S Deficiency Could Lead to Myocardial Infarction in a Very Young Male Adult. Open Access Maced J Med Sci. 2016;4:142-5. PMID:27275349
• 17. Berdeli A, Sekuri C, Sirri Cam F, Ercan E, Sagcan A,Tengiz I, et al. Association between the eNOS(Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population.Clin Chim Acta 2005;351:87-94. PMID:15563875
• 18. Tangürek B, Özer N, Sayar N, Terzi S, Yılmaz HY, Asiltürk R, et al. The relationship between endothelial nitric oxide syntase gene polymorphism (T-786 C) and coronary artery disease in a Turkish population. Türk Kardiyol Dern Ars. 2005;33:467-72. PMID:20098040
• 19. Afrasyap L, Ozturk G. NO level and endothelial NO synthase gene polymorphism (Glu298Asp) in the patients with coronary artery disease from the Turkish population. Acta Biochim Biophys Sin 2004;36:661-6. PMID:15483745
• 20. Poirier O, Mao C, Mallet C, Nicaud V, Herrmann SM, Evans A, et al. Polymorphism of the endotelial nitric oxide synthase gene-no consistent association with myocardial infarction in the ECTİM study. Eur J Clin Invest 1999;29:284-90. PMID:10231340
• 21. Nassar BA, Bevin LD, Johnstone DE, O’Neil BJ, Bata IR, Kirkland SA, et al. Relationship of the Glu 298 Asp polymorphism of the endotelial nitric oxide synthase 47 gene and early-onset coronary artery disease. Am Heart J 2001;142:586-9. PMID:11579346
• 22. Srivastava K, Biswas UK, Narang R, Varghese JJ, Das N. Prevalence of eNOS Glu 298-Asp polymorphism in healty volunteers from region or Northern India. Community Genet 2005;8:180-3. PMID:16113535
• 23. Jaramillo PC, Mumoz MA, Lanas MC, Lanas ZF, Salazar LA. Endothelial nirtic oxidesynthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls. Clin Chem Acta 2006;371:102-6. PMID:16616056
• 24. Casas JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 2004;109:1359-65. PMID:15007011
• 25. Fatini C, Sofi F, Sticchi E, Gensini F, Gori AM, Fedi S, et al. Influence of endothelial nitric oxide synthase gene poliymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J 2004;147:516-21. PMID:14999203
• 26. Rossi GP, Cesari M, Zanchetta M, Colonna S,Maiolino G, Pedon L, et al. The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 2003:41:930-7. PMID:12651036